Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
| CEO | Rick E. Winningham |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 363 |
| Date Founded | 2014 |
| Headquarters | South San Francisco, California |
| Number of Locations | 2 |
| Revenue | $64.4M |
| Net Income | $872,132,000 |
| Tax Rate | -0.3% |
| Total Assets | $607,400,000 |
| Ticker | TBPH |
Theravance Biopharma received early financing of $55.0M on 2015-10-26.
| Series | Round size | Date |
|---|---|---|
| Post-IPO Equity - Theravance Biopharma | $55M | 10/2015 |
| Investors | Security type |
|---|---|
| Woodford Investment Management | Post-IPO Equity - Theravance Biopharma |
Theravance Biopharma's top competitor, Array BioPharma, earned an annual revenue of $173.8M.
Theravance Biopharma's smallest competitor is Arena Pharmaceuticals with revenue of $54.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Array BioPharma | - | $173.8M | 298 | - |
| Matinas BioPharma | - | $1.1M | 20 | - |
| celleng-tech | - | $200,000 | 8 | - |
| Genentech | - | $166.9M | 13,638 | - |
| Genocea | - | - | 59 | - |
| Abbott | - | $42.0B | 109,000 | - |
| Metabolix | - | $9.1M | 50 | - |
| triusrx.com | - | $27.2M | 50 | - |
| Arena Pharmaceuticals | - | $54,000 | 194 | - |
| Cellerant Therapeutics | - | $3.8M | 7 | - |
Zippia gives an in-depth look into the details of Theravance Biopharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Theravance Biopharma. The employee data is based on information from people who have self-reported their past or current employments at Theravance Biopharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Theravance Biopharma. The data presented on this page does not represent the view of Theravance Biopharma and its employees or that of Zippia.
Theravance Biopharma may also be known as or be related to Theravance, Theravance Biopharma, Theravance Biopharma Inc, Theravance Biopharma Us, Inc. and Theravance Biopharma, Inc.